ANDA 76973, held by Fougera Pharmaceuticals. Alclometasone Dipropionate.
As of Nov 21, 2026, ANDA 76973 (Alclometasone Dipropionate), held by Fougera Pharmaceuticals, was first approved by FDA on Jul 12, 2005, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 12, 2005 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Alclometasone Dipropionate0.05% · cream;topical | Alclometasone Dipropionate | Rx |
| Aug 31, 2015 | Supplement 3Labeling · Standard review | Approved | None posted |
| Jul 12, 2005 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters